Showing results (961-970 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|October 27, 2022
Concurrent Olaparib and Radiotherapy in Patients With Triple-Negative Breast Cancer: The Phase 1 Olaparib and Radiation Therapy for Triple-Negative Breast Cancer TrialPierre Loap, Delphine Loirat, Frederique Berger, et al.
JAMA Oncology|June 18, 2025
Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical TrialJulien Taïeb, Francesco Giulio Sullo, Aurélie Lecanu, et al.
JAMA Oncology|May 29, 2025
New Definition of Light Chain Monoclonal Gammopathy of Undetermined SignificanceThorir Einarsson Long, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, et al.
JAMA Oncology|July 3, 2025
Nivolumab and Ipilimumab Combination Treatment in Advanced Ovarian and Endometrial Clear Cell Cancers: A Nonrandomized Clinical TrialBo Gao, Matteo S Carlino, Michael Michael, et al.
JAMA Oncology|April 10, 2025
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation TherapyMarsha Reyngold, Joshua D Schoenfeld, Eileen M O'Reilly, et al.
JAMA Oncology|May 22, 2025
Tomosynthesis vs Digital Mammography Screening in Women with a Family History of Breast CancerTong Li, Yu-Ru Su, Janie M Lee, et al.
JAMA Oncology|October 30, 2025
Consistent Adherence to Physical Activity Guidelines and Digestive System Cancer Risk and MortalityYiwen Zhang, Dong Hoon Lee, Leandro F M Rezende, et al.
JAMA Oncology|September 25, 2025
Emerging EGFR-Targeted Therapy in Head and Neck Cancer: A ReviewWoochan Hwang, Jong Seok Ahn, Hyun Ae Jung, et al.
JAMA Oncology|September 18, 2025
Oral Bacterial and Fungal Microbiome and Subsequent Risk for Pancreatic CancerYixuan Meng, Feng Wu, Soyoung Kwak, et al.
JAMA Oncology|August 14, 2025
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical TrialXingming Zhang, Haoyang Liu, Jiayu Liang, et al.
Pageof 161